The new clinical study on the use of our medical device in the neurological field, started in collaboration with the Agostino Gemelli University Polyclinic IRCCS Foundation, was presented in the latest articles of “Il Sole24 Ore” on “Sanità”.
Related Posts
Adherence to home exercises in rehabilitation is a significant problem and it can depend on several factors…
Via the tablet with app and integrated audio-video channel, the healthcare professional has the opportunity to…
Today, on World Multiple Sclerosis Day, we join hands to show our support for the millions of people who…
The implementation of standards is an integral part of product design and development and plays a key role…
Today, we know how important and necessary continuity of care is. It is increasingly frequent for patients…
Proclaimed in 1992 by the United Nations General Assembly resolution 47/3, the observance of the Day…
The 1st SIAMOC – Società Italiana di Analisi del Movimento in Clinica Workshop on the use of inertial sensors…
Thanks to the use of inertial sensors and validated ai algorithms, ARC allows patients to perform…
It has been observed that average adherence is limited to 50%* when patients with neurodegenerative…
One of our main goals is to guarantee a high level of security and data protection in ARC users’ data management…
We are pleased to announce that ARC intellicare has won a Call for Medical Devices in Neurology, marking…
In ARC we have chosen to implement an AI algorithm that can monitor adherence to the home treatment plan…
More than 2000 participants, 37 panel sessions, and a lot of meetings and emotions. An event marked by…
How can Software Testing help to develop a product able to meet the needs of its users and…
Are you interested to discover and try out a digital AI-powered solution for rehabilitation?